Dr. Bradley MacIntosh:

Midlife Brain Volume and Cognition What 25 year data from the CARDIA study tell us about the importance of Metabolic and Vascular Risk Factors

Learning Objectives:

• Explain why metabolic and vascular risk factors are important over time for the development of vascular cognitive impairment
• Detail how the CARDIA study provides insight about the underlying causes of vascular cognitive impairment
• Describe how the findings of the CARDIA study might be incorporated into clinical practice to better diagnose, and prevent vascular cognitive impairment

Dr. Michael Hill:

Health Behaviours for secondary prevention of stroke – Canadian Stroke Best Practice Recommendations

• Describe the Canadian Stroke Best Practice recommendations, and how to access them
• Explain the natural history of patients following a stroke
• Outline an approach to improve outcomes for patients following a stroke

Dr. Aravind Ganesh:

Save your patient's brain: Cognitive reserve and mitigating progression of vascular cognitive impairment

• Identify the clinical clues that a cognition screen is indicated for your patient
• Describe executive function, and how vascular disease can affect it
• Define cognitive reserve and how to assess it
• Discuss key modifiable factors to address in general practice to maximize reserve and minimize cognitive decline

Dr. Rick Swartz:

1. Building on reductions in vascular cognitive impairment from intensified BP control, lessons from the SPRINT-MIND study, and new SGLT2i data

• Describe the new data on reducing vascular cognitive impairment with blood pressure control and SLT2 inhibitors.
• Explain how blood pressure control and SGLT2 inhibition can impact on the development or worsening of vascular cognitive impairment.